This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Hoffmann-La Roche Inc.. Active years: 2010.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2010
Title: Gerhard Zugmaier: Innovator in Predictive Treatment Methods
Introduction
Gerhard Zugmaier is a notable inventor based in Stuttgart, Germany. He has made significant contributions to the field of medical treatment prediction, particularly in relation to HER inhibitors. His innovative approach aims to enhance patient care by predicting treatment responses.
Latest Patents
Zugmaier holds a patent for a method that predicts the response to treatment with a HER inhibitor. This invention involves assessing biomarkers or a combination of biomarkers, including amphiregulin, epidermal growth factor, transforming growth factor alpha, and HER2, in a biological sample from the patient. The results of this assessment are then used to predict the patient's response to the HER inhibitor treatment.
Career Highlights
Gerhard Zugmaier is associated with Hoffmann-La Roche Inc., a leading company in the pharmaceutical industry. His work focuses on developing methods that improve the efficacy of cancer treatments through personalized medicine.
Collaborations
Zugmaier has collaborated with notable colleagues, including Joachim Moecks and Andreas Strauss. These partnerships have contributed to the advancement of his research and the development of innovative treatment methods.
Conclusion
Gerhard Zugmaier's work in predicting treatment responses represents a significant advancement in personalized medicine. His contributions are vital for improving patient outcomes in cancer treatment.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile